Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroconversion Following RSV Vaccination in Bone Marrow Transplant and CAR-T Patients

NCT07296120 is registered in ClinicalTrials.gov with The Cooper Health System as lead sponsor.

NCT NCT07296120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07296120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroconversion Following RSV Vaccination in Bone Marrow Transplant and CAR-T Patients
Lead sponsor
The Cooper Health System
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
June 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow transplant - autologous or allogeneic, car-t cell therapy, rsv immunization